Download PDF
Nuklearmedizin 1990; 29(06): 252-258
DOI: 10.1055/s-0038-1629540
ÜBersichtsartikel - Review Articles
Schattauer GmbH

Functional and Morphological Findings in Early and Advanced Stages of HIV Infection: a Comparison of 99mTc-HMPAO SPECT with CT and MRI Studies

K. Tatsch
1   From the Department of Radiology (Dir.: Prof. Dr. Dr. h.c. J. Lissner), Klinikum Großhadern, University of Munich, FR Germany
,
Eva Schielke
2   The Department of Neurology (Dir.: Prof. Dr. Th. Brandt), Klinikum Großhadern, University of Munich, FR Germany
,
W. M. Bauer
1   From the Department of Radiology (Dir.: Prof. Dr. Dr. h.c. J. Lissner), Klinikum Großhadern, University of Munich, FR Germany
,
A. Markl
1   From the Department of Radiology (Dir.: Prof. Dr. Dr. h.c. J. Lissner), Klinikum Großhadern, University of Munich, FR Germany
,
K. M. Einhäupl
2   The Department of Neurology (Dir.: Prof. Dr. Th. Brandt), Klinikum Großhadern, University of Munich, FR Germany
,
C.-M. Kirsch
› Author Affiliations
Further Information

Publication History

Received: 02 May 1990

Publication Date:
04 February 2018 (online)

Also available at
    Permissions and Reprints

In fourty patients at early and advanced stages of HIV infection (Walter Reed stages I—VI) regional cerebral blood flow was determined by 99mTc-HMPAO SPECT, comparing the results with CT and MRI findings. All patients with HIV encephalopathy (AIDS dementia complex) had pathologic SPECT results (multilocular, patchy uptake defects), but also in earlier and even earliest stages of HIV infection positive SPECT findings were observed. Compared to functional SPECT imaging, morphologically orientated methods (CT, MRI) were insensitive in detecting HIV-induced foci: more than 50% of the patients with pathologic SPECT findings had negative CT or MRI scans. Most patients in advanced Walter Reed stages had neurological abnormalities accompanied by positive SPECT. Subtle alterations of HMPAO uptake were observed even in a few cases of early HIV infection without neurological CNS symptoms. The data presented suggest that HMPAO SPECT is highly sensitive in the detection of altered brain perfusion not only in advanced but also early stages of HIV infection. Changes in regional cerebral blood flow are present before noticeable structural defects may be observed. Thus, it is suggested to use HMPAO SPECT in the evaluation and monitoring of patients with, and particularly at risk for, HIV encephalopathy.

Zusammenfassung

Bei 40 Patienten in frühen und fortgeschrittenen Stadien der HIV-Infektion (Walter-Reed-Stadien I-VI) wurde mit 99mTc-HMPAO-SPECT der regionale zerebrale Blutfluß untersucht und die Ergebnisse dem jeweiligen CT- und MR-Befund gegenübergestellt. Alle Patienten mit manifester HIV-Enzephalopathie (AIDS-De- menz-Komplex) hatten pathologische SPECT-Befunde (multilokulare Speicherdefekte), aber auch in frühen und sehr frühen Stadien der HIV-Infektion wurden bereits positive SPECT-Befunde erhalten. Im Gegensatz zu der funktionsorientierten SPECT-Un- tersuchung erwiesen sich die morphologisch ausgerichteten Diagnoseverfahren (CT, MR) als wenig sensitiv beim Nachweis HIV-induzierter Foci: Mehr als 50% der Patienten mit pathologischen SPECT-Ergebnissen zeigten unauffällige CT- bzw. MR-Befunde. Die Mehrzahl der Patienten im fortgeschrittenen Walter-Reed- Stadium war bei pathologischem SPECT-Befund auch neurologisch auffällig. Speicherdefekte von geringerem Ausmaß traten bereits bei einigen Patienten im Frühstadium und ohne ZNS-Symptomatik auf. Nach den vorliegenden Daten stellt HMPAO-SPECT ein hochsensitives Nachweisverfahren für zerebrale Perfusionsstörungen nicht nur in fortgeschrittenen, sondern auch frühen Stadien der HIV-Infektion dar. Änderungen des regionalen zerebralen Blutflusses sind nachweisbar, bevor morphologische Defekte faßbar werden. Untersuchungen mit HMPAO-SPECT bieten sich daher zur Abklärung und Verlaufsbeobachtung von Patienten mit und insbesondere bereits bei Verdacht auf HIV-Enzephalopathie an.

 

  • References

  • 1 Barnes D M. Rallying against AIDS: brain endothelial cells infected by AIDS virus (news). Science 1986; 233: 418-9.
    CrossrefPubMedGoogle Scholar
  • 2 Cho E S, Sharer L R, Peress N S, Little B. Intimal proliferation of leptomeningeal arteries and brain infarcts in subjects with AIDS. J Neuropathol Exp Neurol 1987; 46: 385.
    Google Scholar
  • 3 Costa D C, Ell P J, Burns A, Philot M, Levy R. CBF tomograms with “mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson’s disease - initial results. J Cereb Blood Flow Metab 1988; 08 (Suppl. 01) 109-15.
    CrossrefPubMedGoogle Scholar
  • 4 Ell P J, Dosta D C, Harrison M. Imaging cerebral damage in HIV infection. Lancet 1987; ii: 569-70.
    PubMedGoogle Scholar
  • 5 Engstrom J W, Lowenstein D H, Bredesen D E. Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am J Med 1989; 86: 528-32.
    CrossrefPubMedGoogle Scholar
  • 6 Fischer P A, Enzensberger W. Neurological complications in AIDS. J Neurol 1989; 234: 269-79.
    Google Scholar
  • 7 Gray F, Gherardi R, Scaravilli F. The neuropathology of the acquired immune deficiency syndrome (AIDS). Brain 1988; 111: 245-66.
    CrossrefPubMedGoogle Scholar
  • 8 Gyorkey F, Melnick J L, Gyorkey P. Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J Infect Dis 1987; 155: 870-6.
    CrossrefPubMedGoogle Scholar
  • 9 Ho D D, Pomerantz R J, Kaplan J C. Pathogenesis of infection with immunodeficiency virus. N Engl J Med 1987; 317: 278-86.
    CrossrefPubMedGoogle Scholar
  • 10 Joshi V V, Pawel B, Connor E. et al. Arteriopathy in children with acquired immune deficiency syndrome. Pediatric Pathol 1987; 07: 261-75.
    Google Scholar
  • 11 Kelly W M, Brant-Zawadzki M. Acquired immunodeficiency syndrome: Neuroradiologic findings. Radiology 1983; 149: 485-91.
    CrossrefPubMedGoogle Scholar
  • 12 Levy R M, Bredesen D E, Rosenblum M L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at the USCF and review of the literature. J Neurosurg 1985; 62: 475-95.
    CrossrefPubMedGoogle Scholar
  • 13 Levy R M, Rosenbloom S, Perrett L V. Neuroradiological findings in AIDS: A review of 200 cases. Am J Radiol 1986; 147: 977-83.
    Google Scholar
  • 14 Mizusawa H, Hirano A, Llena J F, Shintaku M. Cerebrovascular lesions in acquired immune deficiency syndrome. Acta Neuropathol 1988; 76: 451-7.
    CrossrefPubMedGoogle Scholar
  • 15 de la Monte S, Ho D D, Schooley R T, Hirsch M S, Richardson E P. Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology 1988; 37: 562-9.
    Google Scholar
  • 16 Navia B A, Jordan B D, Price R W. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19: 517-24.
    CrossrefPubMedGoogle Scholar
  • 17 Navia B A, Cho E-S, Petito C K, Price R W. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986; 19: 525-35.
    CrossrefPubMedGoogle Scholar
  • 18 Pert C B, Smith C C, Ruff M R, Hill J M. AIDS and its dementia as a neuropeptide disorder: role of VIP receptor blockade by human immunodeficiency virus envelope. Ann Neurol 1988; 22: 700-6.
    Google Scholar
  • 19 Pohl P, Vogl G, Fill H. et al. Single photon emission computed tomography in AIDS dementia complex. J Nucl Med 1988; 29: 1382-6.
    PubMedGoogle Scholar
  • 20 Post M J D, Sheldon J J, Hensley G T. et al. Central nervous system disease in acquired immunodeficiency syndrome: Prospective correlation using CT, MR imaging, and pathologic studies. Radiology 1986; 158: 141-8.
    CrossrefPubMedGoogle Scholar
  • 21 Post M J D, Tate L G, Quencer R M. et al. CT, MR, and pathology in HIV encephalitis and meningitis. Am J Neuroradiol 1988; 09: 469-76.
    Google Scholar
  • 22 Pumarola-Sune T, Navia B A, Cordon- Carda C, Cho E-S, Price R W. HIV antigen in the brain of patients with the AIDS dementia complex. Ann Neurol 1987; 21: 490-6.
    CrossrefPubMedGoogle Scholar
  • 23 Price R W, Brew B J. The AIDS dementia complex. J Infect Dis 1988; 158: 1079-83.
    CrossrefPubMedGoogle Scholar
  • 24 Redfield R R, Wright D C, Tramont E C. The Walter Reed Staging Classification for HTLV-III/LAV infection. N Engl J Med 1986; 314: 131-2.
    CrossrefPubMedGoogle Scholar
  • 25 Rottenberg D A, Moeller J R, Strother S C. et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987; 22: 700-6.
    CrossrefPubMedGoogle Scholar
  • 26 Snider W D, Simpson D M, Nielsen S. et al. Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol 1983; 14: 403-18.
    CrossrefPubMedGoogle Scholar
  • 27 Whelan M A, Kricheff II, Handler M. et al. Acquired immunodeficiency syndrome: Cerebral computed tomographic manifestations. Radiology 1983; 149: 477-84.
    CrossrefPubMedGoogle Scholar
  • 28 Wiley C A, Schrier R D, Nelson J A, Lampert P W, Oldstone MBA. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sei (USA) 1986; 83: 7089-93.
    CrossrefPubMedGoogle Scholar